Both in Pharmaceuticals
Crescent Biopharma vs Ovid Therapeutics
Over the past year CBIO returned +4.5% and OVID returned +73.2%; their daily moves had a correlation of 0.27.
CBIO +4.5% OVID +73.2%Growth of $1, one year, split-adjusted
| Metric | CBIO | OVID |
|---|---|---|
| Price | $12.91 | $2.39 |
| Market cap | $479.6M | $466.8M |
| Today | −4.23% | −5.91% |
| 1 month | −9.8% | +0.4% |
| 6 months | −28.0% | −18.4% |
| Year to date | +8.9% | +46.6% |
| 1 year | +3.2% | +74.5% |
| Revenue growth (YoY) | — | −88.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −2047.6% |
| P/E (TTM) | — | — |
| Price / sales | 40.4× | 294.9× |
| Net cash | $171.6M | $117.2M |
| Dividend yield | — | — |
| Volatility (60d) | 69.2% | 59.0% |
| Short % of float | 21.2% | 10.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).